Duke Surgical Oncology shared a post on X:
“Thought-provoking trial of single-dose neoadjuvant hepatic artery chemo for localized pancreatic cancer ongoing at Duke University Department of Surgery, Duke Cancer Institute, led by Dr. Daniel Nussbaum and presented by Duke University School of Medicine student Ethan Agritelley at SSO2025.”
More posts featuring Duke Surgical Oncology.